文献速递眼底病与葡萄膜炎

澳大利亚年龄相关性黄斑变性患病率:澳大利亚全国眼健康调查

Prevalence of Age-Related Macular Degeneration in Australia: The Australian National Eye Health Survey.
PubMed 文献 · JAMA Ophthalmol · 2017-01-01

该基于人群的横断面调查于2015年3月11日至2016年4月18日在澳大利亚30个地理区域检查了4836人,其中3098名50岁及以上非原住民和1738名40岁及以上原住民。非原住民早期AMD加权患病率为14.8%、中期为10.5%、晚期为0.96%;原住民早期为13.8%、中期为5.7%、晚期仅3例。非原住民中AMD是11.1%视力丧失者的主要原因,原住民中为1.1%。

要点

  • 非原住民50岁及以上早期AMD加权患病率14.8%,中期10.5%,晚期0.96%。
  • 原住民40岁及以上早期AMD加权患病率13.8%,中期5.7%,晚期仅3例(0.17%)。
  • 非原住民晚期AMD患病率在80岁及以上升至6.7%,男性高于女性(1.4% vs 0.61%,P=0.02)。

核心结论

  • 与其他白种人群数据一致,AMD是非原住民澳大利亚人视力丧失的重要原因。
  • 为应对澳大利亚AMD预计的增加,可能需要增加低视力康复服务的提供。

研究设计与样本

  • 基于人群的横断面调查,2015年3月11日至2016年4月18日在澳大利亚30个地理区域开展。
  • 检查3098名50岁及以上非原住民澳大利亚人和1738名40岁及以上原住民澳大利亚人。
  • 共4836人接受检查,其中4589人(94.9%,非原住民2946人、原住民1643人)至少1眼视网膜照片可用于AMD分级。
  • AMD按Beckman临床分类系统分为任何AMD、早期AMD、中期AMD和晚期AMD。

主要发现

  • 非原住民早期AMD加权患病率14.8%(95%CI 11.7%-18.6%),中期AMD加权患病率10.5%(95%CI 8.3%-13.1%)。
  • 原住民早期AMD加权患病率13.8%(95%CI 9.7%-19.3%),中期AMD加权患病率5.7%(96%CI 4.7%-7.0%,原文此处写作96%CI,按上下文应为95%CI)。
  • 非原住民晚期AMD患病率0.96%(95%CI 0.59%-1.55%),其中萎缩型0.72%、新生血管型0.24%。
  • 原住民中仅3例(0.17%[95%CI 0.04%-0.63%])有晚期(萎缩型)AMD。
  • 非原住民80岁及以上晚期AMD患病率升至6.7%,男性高于女性(1.4% vs 0.61%,P=0.02)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Age-related macular degeneration (AMD) is a leading cause of irreversible blindness among the elderly population globally. Currently, knowledge of the epidemiology of AMD in Australia remains scarce because of a paucity of recent population-based data. OBJECTIVE: To examine the prevalence of AMD in Australia. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, cross-sectional survey performed from March 11, 2015, to April 18, 2016, a sample of 3098 nonindigenous Australians 50 years and older and 1738 indigenous Australians 40 years and older from 30 geographic areas across Australia were examined. MAIN OUTCOMES AND MEASURES: Any AMD, early AMD, intermediate AMD, and late AMD graded according to the Beckman clinical classification system. RESULTS: A total of 4836 individuals were examined, including 3098 nonindigenous Australian (64.1%; 58.9% female vs 41.1% male; age range, 40-92 years; mean [SD] age, 55.0 [10.0] years) and 1738 indigenous Australians (35.9%; 53.6% female vs 46.4% male; age range, 50-98 years; mean [SD] age, 66.6 [9.7] years). A total of 4589 (94.9%, 2946 nonindigenous and 1643 indigenous) participants had retinal photographs in at least 1 eye that were gradable for AMD. The weighted prevalence of early AMD was 14.8% (95% CI, 11.7%-18.6%) and of intermediate AMD was 10.5% (95% CI, 8.3%-13.1%) among nonindigenous Australians. In indigenous Australians, the weighted prevalence of early AMD was 13.8% (95% CI, 9.7%-19.3%) and of intermediate AMD was 5.7% (96% CI, 4.7%-7.0%). Late AMD was found in 0.96% (95% CI, 0.59%-1.55%) of nonindigenous participants (atrophic, 0.72%; neovascular, 0.24%). The prevalence of late AMD increased to 6.7% in participants 80 years or older and was higher in men (1.4% vs 0.61%, P = .02). Only 3 (0.17% [95% CI, 0.04%-0.63%]) indigenous participants had late (atrophic) AMD. Age-related macular degeneration was attributed as the main cause of vision loss (<6/12 in the better eye) in 23 of 208 nonindigenous Australians (11.1%) and 2 of 183 indigenous Australians (1.1%). CONCLUSIONS AND RELEVANCE: In line with data from other white populations, AMD is a prominent cause of vision loss in the nonindigenous Australian population. An increased provision of low vision rehabilitation services may be required to cope with the projected increase in AMD in Australia.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Keel S, Xie J, Foreman J, et al. Prevalence of Age-Related Macular Degeneration in Australia: The Australian National Eye Health Survey. JAMA Ophthalmol. 2017. PMID: 29049463. doi:10.1001/jamaophthalmol.2017.4182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。